Showing results (361-370 of 453) with videos related to
Sort By:
Pageof 46
Voprosy Onkologii|January 1, 1991
[The prevention of the hypercoagulation syndrome during the combined treatment of lung cancer patients using artificial hyperglycemia]S Z Fradkin, E A Zhavrid, V I Prokhorova, et al.AJNR. American Journal of Neuroradiology|March 2, 2026
Decoding MRI Presentation of Primary Central Nervous System Diffuse Large B Cell Lymphoma: A Novel Subgroup PerspectiveRaffaello Bonacchi, Teresa Calimeri, Ivan Shashkin, et al.The Journal of Pediatrics|April 8, 2004
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipientsJames L Mills, Lawrence B Schonberger, Diane K Wysowski, et al.Developmental Biology|July 30, 2004
The Drosophila Wnt5 protein mediates selective axon fasciculation in the embryonic central nervous systemLee G Fradkin, Martijn van Schie, Rene R Wouda, et al.Familial Cancer|February 18, 2009
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancerMarijana Lijovic, Susan R Davis, Pam Fradkin, et al.Anesteziologiia I Reanimatologiia|November 1, 1990
[Infusion therapy in sessions of general artificial hyperthermia using large doses of insulin in cancer patients]S E Nodel'son, M V Bronshteĭn, E B Belenkova, et al.Physical Review Letters|May 21, 2010
Anomalous noise in the pseudogap regime of YBa2Cu3O(7-delta)D S Caplan, V Orlyanchik, M B Weissman, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2006
Dystrophin is required for appropriate retrograde control of neurotransmitter release at the Drosophila neuromuscular junctionMariska C van der Plas, Gonneke S K Pilgram, Jaap J Plomp, et al.Nature Neuroscience|October 16, 2007
Antagonistic roles of Wnt5 and the Drl receptor in patterning the Drosophila antennal lobeYing Yao, Yuping Wu, Chong Yin, et al.Journal of Women'S Health (2002)|January 5, 2010
Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancerRobin J Bell, Marijana Lijovic, Pam Fradkin, et al.Pageof 46